Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
0.950
+0.044 (4.86%)
At close: Mar 9, 2026, 4:00 PM EDT
0.956
+0.006 (0.66%)
After-hours: Mar 9, 2026, 4:43 PM EDT
Biodexa Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1 | 2 | 7 | 4 | 13 | 23 | |
| Market Cap Growth | -68.64% | -66.49% | 64.98% | -67.32% | -43.85% | 52.91% | |
| Enterprise Value | -4 | -4 | 1 | -3 | 8 | 22 | |
| Last Close Price | 0.91 | 40.50 | 670.00 | 78800.00 | 420000.00 | 748000.00 | |
| PS Ratio | - | - | 14.47 | 5.05 | 16.64 | 49.52 | |
| PB Ratio | 0.04 | 0.23 | 1.18 | 1.12 | 0.92 | 2.53 | |
| P/TBV Ratio | 0.10 | 0.70 | 3.17 | 1.12 | 0.92 | 2.53 | |
| EV/Sales Ratio | - | - | 2.20 | - | 10.65 | 47.35 | |
| Debt / Equity Ratio | 0.04 | 0.09 | 0.10 | 0.20 | 0.07 | 0.04 | |
| Net Debt / Equity Ratio | -0.31 | -0.11 | -1.18 | -0.70 | -0.89 | -1.08 | |
| Net Debt / EBITDA Ratio | 0.40 | 0.10 | 0.84 | 0.25 | 1.37 | 0.76 | |
| Net Debt / FCF Ratio | 0.33 | 0.08 | 0.80 | 0.31 | 1.47 | 0.77 | |
| Asset Turnover | - | - | 0.05 | 0.08 | 0.05 | 0.02 | |
| Quick Ratio | 3.63 | 0.47 | 1.20 | 2.27 | 6.06 | 3.02 | |
| Current Ratio | 3.63 | 1.75 | 1.26 | 2.47 | 6.39 | 3.10 | |
| Return on Equity (ROE) | -61.77% | -88.14% | -180.59% | -112.47% | -63.60% | -168.89% | |
| Return on Assets (ROA) | -39.04% | -45.41% | -52.16% | -60.55% | -38.48% | -32.76% | |
| Return on Capital Employed (ROCE) | -72.80% | -94.40% | -134.80% | -246.40% | -63.20% | -156.30% | |
| Earnings Yield | -1122.63% | -304.90% | -128.44% | -216.78% | -56.78% | -130.65% | |
| FCF Yield | -1899.88% | -653.01% | -124.32% | -201.33% | -65.81% | -55.99% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.